The Nation (Nairobi)

Kenya: Obel Claims Discovery of Another Aids Drug

Amina Kibirige

6 June 2008


Nairobi — Controversial Kenyan scientist Arthur Obel Thursday claimed he had yet again discovered a drug for HIV and Aids.

Making the announcement in Mombasa in an exclusive interview, Prof Obel said his new drug, named OSCean could reduce an infected person's viral load to zero.

"The drug shall be launched on the 16th of June in Nairobi, and the initial treatments shall be offered free of charge for as long as the stocks can last," said Prof Obel, soon after opening the Third East African Project Management Summit at the Sarova Whitesands.

But Medical Services assistant minister Danson Mungatana asked Prof Obel to immediately take the drug to be tested for efficacy by the Pharmacy and Poisons Board.

"This is the procedure that all drugs in our market are expected to follow before they are put on the market," Mr Mungatana said.

Speaking on telephone, Mr Mungatana said it was "impossible" at this stage to state whether the new drug works, until testing was carried out by professionals.

More potent

OSCean is the fourth drug the Aids researcher has come up with, terming each subsequent discovery more potent than the previous one.

It comes four years after Compound Q27 and 11 years after Pearl Omega, which was banned by the authorities.

Be the first to Write a Comment!

Copyright © 2008 The Nation. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica aggregates and indexes content from over 125 African news organizations, plus more than 200 other sources, who are responsible for their own reporting and views. Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica.



Sign up for FREE daily 'top headlines' by email »


SELECT
SELECT

Most Active Stories: Kenya

Ask Obama a Question